Founding Team
David Wang, BMed | CEO & co-founder
A medical-background executive with nearly 40 years of cross-functional leadership, David Wang leverages deep corporate scaling expertise—including serving as General Manager for “K” Line Air Service (Hong Kong) Ltd. and HK Deloitte Industrial—to drive commercial growth and investor value for advanced AI-aided drug discovery platforms.
Bixia Ge, PhD | CSTO & co-founder
An experienced scientist and entrepreneur, with over 20 years of R&D management and commercialization experience, Dr. Ge has successfully scaled innovations across the biosensor, biotechnology, and biomedicine industries to maximize investor value and technological growth.
Ze Zhu, BMed, PhD | CMO & co-founder
A prominent academic and clinical leader, Dr. Zhu serves as a Professor of Pathogen Biology at Tianjin Medical University and leverages elite global credentials as a member of the American Association for Cancer Research (AACR), the American Association of Pharmaceutical Scientists (AAPS), and the Chinese American Biopharmaceutical Society (CABS) to ground the company’s pipeline in world-class scientific and clinical validation.
Jason Shen, BMed | Co-founder
A medically trained physician and researcher with over three decades of clinical trial expertise, Jason Shen possesses deep specialization in immunomodulatory natural product development and a proven track record in the commercialization of therapeutic health products.
Advisor Network
NovaLinko is supported by a network of clinical advisors, academic collaborators, and industry consultants spanning oncology, virology, and regulatory affairs. Details available upon request.
“A lean, execution-focused team with complementary expertise — from computational discovery to clinical translation, we have every critical function covered.”